Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 16:19:eRB5996.
doi: 10.31744/einstein_journal/2021RB5996. eCollection 2021.

MicroRNAs: understanding their role in gene expression and cancer

[Article in English, Portuguese]
Affiliations
Review

MicroRNAs: understanding their role in gene expression and cancer

[Article in English, Portuguese]
Ariany Lima Jorge et al. Einstein (Sao Paulo). .

Abstract

MicroRNAs are small RNA molecules that regulate gene expression in cells. These small molecules comprise 17 to 25 nucleotides and are able to recognize target messenger RNAs by sequence complementarity and regulate their protein translation. Different microRNAs are expressed in all human cells. There is over 2,500 microRNAs described in humans that are involved in virtually all biological processes. Given their role as gene expression regulators, these molecules have been widely investigated and are thought to be associated with some specific physiological and pathological conditions, being proposed as biomarkers. It has recently been reported that microRNAs are secreted outside cells and are involved in intercellular communication. MicroRNAs in biological fluids are named circulating and have been detected in all body fluids, although the expression profile is specific for each type. The major advantages of using circulating microRNAs as biological markers are the high stability of those molecules and the wide availability of samples. Also, given the individual nature of microRNA expression changes, these molecules have a high potential for use in personalized medicine. In fact, microRNA expression profile determination may support disease recognition and diagnosis, and can be used to monitor therapeutic responses and establish patient prognosis, assisting in choice of treatment. This review provides a general overview of microRNAs and discusses the importance of those molecules in cancer, for deeper understanding of their role in this disease.

RESUMO: Os microRNAs são pequenas moléculas de RNAs que regulam a expressão gênica das células. Com entre 17 e 25 nucleotídeos, essas pequenas moléculas reconhecem RNA mensageiro-alvo, por meio da complementariedade entre as sequências, e regulam sua tradução proteica. Todas as células humanas expressam diversos microRNAs. De fato, existem mais de 2.500 microRNAs descritos em humanos, relacionados com praticamente todos os processos biológicos. Devido ao seu papel como reguladores da expressão gênica, essas moléculas têm sido estudadas e relacionadas com algumas condições fisiológicas e patológicas específicas, sendo propostas como biomarcadores. Recentemente, foi descoberto que os microRNAs são normalmente liberados para fora da célula, onde participam da comunicação intercelular. MicroRNAs presentes nos fluidos biológicos são chamados de circulantes e têm sido encontrados em todos os fluidos corporais, porém o perfil de expressão é específico para cada tipo. O uso de microRNAs circulantes como marcadores biológicos apresenta vantagens relacionadas com a alta estabilidade dessas moléculas e a facilidade de obtenção de amostra. Adicionalmente, considerando que as alterações em microRNAs são dependentes das condições individuais, essas moléculas apresentam alto potencial de uso na medicina personalizada. De fato, a determinação do perfil de expressão de microRNAs pode auxiliar na identificação e diagnóstico de doenças, no monitoramento de respostas terapêuticas e na definição do prognóstico dos pacientes, auxiliando na escolha do tratamento. Nesta revisão são apresentados aspectos gerais dos microRNAs, e discute-se a importância dessas moléculas no câncer, visando a uma melhor compreensão de seu papel nessa doença.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Canonical microRNA biogenesis pathway. This pathway begins with nuclear transcription of microRNAs into molecules named pri-microRNAs. Pri-microRNAs are then processed by the nuclear enzyme Drosha to generate smaller molecules, the so-called pre-microRNAs. Pre-microRNAs are exported to the cytoplasm by exportin-5, then processed by the enzyme Dicer, giving rise to double-stranded microRNA molecules, which bind to RNA-induced silencing complex. The strands of bound microRNAs are then separated, originating to mature microRNAs, which are able to bind to messenger RNAs and inhibit their translation
Figura 1
Figura 1. Biogênese canônica de microRNAs. Os microRNAs são primeiramente traduzidos no núcleo em moléculas denominadas pri-microRNAs. A partir de sequências de DNA, os pri-microRNAs são processados pela enzima nuclear Drosha, dando origem a uma molécula menor, chamada pré-microRNA. O pré-microRNA é exportado ao citoplasma, com a ajuda da exportina-5, no qual será processado pela enzima Dicer, gerando uma molécula de microRNA de fita dupla, que se acoplará ao complexo proteico silenciador induzido por RNA. O microRNA associado ao complexo silenciador induzido por RNA terá suas fitas separadas, dando origem a microRNAs maduros e capazes de se ligar aos RNAs mensageiros, inibindo sua tradução

References

    1. Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene. 2006;25:6170–6175. Review. - PubMed
    2. 1. Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene. 2006;25:6170-5. Review. - PubMed
    1. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854. - PubMed
    2. 2. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843-54. - PubMed
    1. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018;9:402–402. Review. - PMC - PubMed
    2. 3. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402. Review. - PMC - PubMed
    1. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018;47(D1):D155–D162. - PMC - PubMed
    2. 4. Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2018;47(D1):D155-D62. - PMC - PubMed
    1. Walayat A, Yang M, Xiao DL. Therapeutic implication of miRNA in human disease. In: Sharad S, Kapur S, editors. Antisense therapy. London: IntechOpen; 2018. pp. 1–20. Chapter 6.
    2. 5. Walayat A, Yang M, Xiao DL. Therapeutic implication of miRNA in human disease. In: Sharad S, Kapur S. Antisense therapy. London: IntechOpen; 2018. Chapter 6. p.1-20.